Infection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.
The journal is characterized by the rapid reporting of high-quality original research, reviews, guidelines, expert opinions, commentary and clinical studies in all areas of infection and drug resistance.
Infection and Drug Resistance will no longer consider meta-analyses for publication.
Specific topics covered by the journal include:
Development of novel anti-infectives
Optimal use of existing anti-infectives
Pathogenesis and etiology of infectious disease
Proteomic and genomic studies in resistant organisms
Mechanisms of resistance development
Vaccine development and implementation
Infection control in hospitals and the community
Diagnosis and early detection of infection
Clinical management of infection
Clinical management of antibiotic resistance (e.g. in transplant and HIV patients)
Epidemiology of infection and antibiotic resistance
Education and prevention of drug resistance
Patient adherence and satisfaction
The journal does not accept study protocols. The journal will consider case reports only if they make a valuable and original contribution to the literature.
When considering submission of a paper utilizing publicly-available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.
Journal metrics
Usage
596K annual downloads/views
Citation metrics
2.9 (2023) Impact Factor
Q2 Impact Factor Best Quartile
3.6 (2023) 5 year IF
5.6 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.947 (2023) SNIP
0.743 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Suresh Antony, (Clinical Professor), Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA
Associate Editors-in-Chief
Héctor M. Mora Montes, (Senior Researcher) Department of Biology, Division of Natural and Exact Sciences, University of Guanajuato, Guanajuato, Mexico
Sandip Patil, (Researcher), Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China
Zhi Ruan, (Principal Investigator), Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Editorial Board
Itzhak Brook, (GUMC Adjunct Professor), Georgetown University School of Medicine, Washington D.C., USA
Keertan Dheda, (Professor and Director), University of Cape Town, Cape Town, South Africa; Professor of Mycobacteriology and Global Health, London School of Hygiene and Tropical Medicine, London, UK
Jonathan Dinman, (Professor and Affiliate Fellow), Virus Adaptation and Treatment, University of Maryland, College Park, Maryland, USA
Varsha Gupta, (Professor), Department of Microbiology, Governmental Medical College and Hospital, Chandigarh, India
Mercy Jemima Newman, (Associate Professor), School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana, West Africa.
George R. Thompson 3rd, (Professor), Department of Medicine, Division of Infectious Diseases, Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, California, USA
Min Wu, (Professor), Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA and and Wenzhou Institute of University of Chinese Academy of Sciences,Wenzhou, Zhejiang, China
Abstracting and indexing
Infection and Drug Resistance is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Journal Citation Reports/Science Edition
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Science Citation Index Expanded (Clarivate Analytics)
Scopus (Elsevier)
Open access
Infection and Drug Resistance is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})